Alton Ochsner Medical Center

New Orleans, Louisiana 70121

0 studies enrolling now · 2 studies all time

What they study most

Soft Tissue Sarcoma, Urothelial Carcinoma

Studies at this site

• Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma — APPROVED_FOR_MARKETING
• A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer — Completed